In Brief: Conceptus
This article was originally published in The Gray Sheet
Conceptus: Delivers to the U.S. market its first products, the Soft-Seal cervical catheter and Soft-Torque uterine catheter systems, following FDA clearance of the devices. The catheters are designed "to improve the accuracy" of current infertility diagnostic procedures and are indicated for use in hysterosalpingography and chromopertubation. The Soft-Torque also was cleared for use in intrauterine insemination...
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.